Free CME from PeerView


Allergy & Immunology CME

Kenji Kabashima, MD, PhD
Credits: 1 CME
PVI, PeerView Institute for Medical Education
Expert Insights From Around the Globe on Tailoring Treatment for Patients With Atopic Dermatitis
Emma Guttman-Yassky, MD, PhD
November 2, 2021
Credits: 1 CME / MOC / CC
Medical Learning Institute, Inc.
Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings
Lynette M. Sholl, MD
October 28, 2021
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Changing the Game for Patients With Prurigo Nodularis: Best Practices to Achieve Treatment Goals and Improve Quality of Life
October 28, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team
October 28, 2021
Credits: 1 CME / NCPD / CPE
Medical Learning Institute, Inc.
Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach
Benjamin M. Greenberg, MD, MHS
October 27, 2021
Credits: 1 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Exploring the Convergence of Advances in S1P Receptor Modulation With Progress in Understanding Brain Atrophy and Cognition Measures in Multiple Sclerosis
Bruce Cree, MD, PhD, MAS
October 25, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Maintaining Vigilance to Mitigate Cancer Immunotherapy-Related Toxicities in the Emergency Department: Be Aware, Stay Alert, and Change Your Practice
Christopher Baugh, MD, MBA, Mark M. Awad, MD, PhD
October 24, 2021
Credits: 1.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Fulfilling a Need in the Management of Patients With Eosinophilic Esophagitis: An Exploration of Novel and Emerging Therapeutic Options
Evan S. Dellon, MD, MPH
October 22, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape
October 21, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
Integrating the Latest Evidence Into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe Atopic Dermatitis
October 19, 2021
Todd Mosher
Credits: 0.5 CME
Medical Learning Institute, Inc.
Advancing Treatment of von Willebrand Disease: A Visual Exploration on Personalizing Care With Current and Emerging Management Strategies
October 14, 2021
Credits: 1 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Putting a Personalized Colorectal Cancer Treatment Algorithm Into Practice: Navigating Practicalities in the Era of Molecularly Defined Care
Prof Eric Van Cutsem, MD, PhD
October 13, 2021
Credits: 0.50 CME
Penn State College of Medicine
Improving the Recognition and Effective Management of Axial Spondyloarthritis: Practical Guidance for the Primary Care Provider
Philip J. Mease, MD, MACR
October 12, 2021
Credits: 1.00 CME / MOC / NCPD
Medical Learning Institute, Inc.
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
Anthony R. Mato, MD, MSCE
October 4, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Breaking Therapeutic Barriers in RRMM: Team-Based Solutions for Integrating Novel Antibody Platforms and Improving Myeloma Care
Sagar Lonial, MD, FACP
October 1, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Heart Failure Society of America
Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding and Addressing Its Pathophysiology
Daniel Jacoby, MD
October 1, 2021
Credits: 0.25 CME
Johns Hopkins University School of Medicine
Advances in the Management of IBD: Expert Insight on What’s New and What’s Next
Aline Charabaty, MD, AGAF, FACG
September 29, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Raising the Bar for Patient Outcomes With Transcription Inhibition and Other New Options in the Treatment Arsenal for SCLC: Rationale, Mechanisms of Action, Latest Data, and Practicalities of Clinical Use in Oncology Practice
Jared Weiss, MD
September 29, 2021
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Kurt A. Schalper, MD, PhD
September 28, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Taking Action in Advanced Biliary Cancers: Expert Insights on Integrating Newly Available and Innovative Therapeutics to Deliver Precision-Based Care
Milind Javle, MD
September 28, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe Asthma
Ian Pavord, FMedSci
September 27, 2021
Credits: 0.25 NCPD
Medical Learning Institute, Inc.
Ushering in a New Wave of Progress in Advanced Hepatobiliary Cancers: Expert Perspectives on Incorporating New Evidence and Innovative Therapeutics to Deliver Optimal, Patient-Centered Care
Jackie Weatherly, PA-C
September 27, 2021
Credits: 0.75 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on Advances in Diagnosis, Severity Grading, and Treatment
Kenneth R. Cooke, MD
September 24, 2021
Credits: 0.50 CME / MOC / CC
Medical Learning Institute, Inc.
Secondary AML Through the Microscope: A Pathology-Informed Guide to Modern Diagnostic and Treatment Principles
Sanam Loghavi, MD
September 20, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Taking Aim at the TYK2 Pathway in Psoriasis: Addressing Unmet Treatment and Patient Needs With an Innovative Therapeutic Approach
April W. Armstrong, MD, MPH
September 17, 2021
Credits: 0.50 CME / NCPD
Medical Learning Institute, Inc.
Test Your Knowledge of New and Emerging Therapies for Moderate to Severe Atopic Dermatitis: Latest Evidence and Clinical Potential
Jonathan I. Silverberg, MD, PhD, MPH
September 17, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD
September 14, 2021
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Srdan Verstovsek, MD, PhD
September 10, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care
Nicole Lamanna, MD
September 9, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
The Next Building Block for B-Cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
September 8, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView